MedPath

Pearson Mepivacaine

Mepivacaine HCl 3% (Mepivacaine Hydrochloride Injection, USP)

Approved
Approval ID

d303afcf-73b3-4dbf-88c9-0ae20f0d879a

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 30, 2017

Manufacturers
FDA

Pearson Dental

DUNS: 082874108

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Mepivacaine Hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code43305-1080
Application NumberANDA088387
Product Classification
M
Marketing Category
C73584
G
Generic Name
Mepivacaine Hydrochloride
Product Specifications
Route of AdministrationSUBCUTANEOUS
Effective DateNovember 30, 2017
FDA Product Classification

INGREDIENTS (3)

Mepivacaine HydrochlorideActive
Quantity: 30 mg in 1 mL
Code: 4VFX2L7EM5
Classification: ACTIB
Sodium ChlorideInactive
Quantity: 6 mg in 1 mL
Code: 451W47IQ8X
Classification: IACT
WaterInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Pearson Mepivacaine - FDA Drug Approval Details